scott@vtx-cpd.com
Forum Replies Created
-
AuthorPosts
-
Replying to Nikki McLeod 29/03/2024 - 10:22
Hello Nikki.
Thank you so much for joining the course. We really appreciate you being so supportive of vtx.
Have a great week.
Scott π
Replying to Helen S. 25/03/2024 - 09:32
We are so lucky to have you Helen!
I hope you are having a lovely week.
Scott π
Replying to Helen D. 24/03/2024 - 21:42
Helen!
Really lovely to hear from you. I hope you are well and enjoying the course.
Thank you for the brilliant question. I am not sure that anyone has specifically looked at the timing of maropitant administration in brachycephalic dogs. I would normally give on the morning of the procedure when I was giving other medication or at the time of premedication.
I do not specifically change my approach with PPI use in raw fed dogs. Do you mean due to the effect that the change in acidity will have on the food digestion and bacterial load?
I think I am just careful with the use of PPI’s generally and only use them when I gave a specific indication. I have also forwarded your question to our anaesthetist Felipe for his comment too.
Scott π
Replying to Erin B. 24/03/2024 - 20:20
Hey Erin.
Thank you again for another brilliant question.
In cases of patients with non-surgical mast cell tumours (MCTs), the use of gastroprotectants should be considered based on the individual patient’s risk factors for gastrointestinal ulceration. While prophylactic use of gastroprotectants is not typically indicated in all cases of non-surgical MCTs, it may be warranted in patients with known risk factors such as a history of gastrointestinal ulceration, or signs suggestive of gastrointestinal ulceration (e.g., vomiting, melena). I would not necessarily use gastroprotectants just because they are on concurrent steroids or NSAIDs either. The decision to use gastroprotectants prophylactically should be made on a case-by-case basis, weighing the potential benefits against the risks.
Having said that, I do not have loads of experience managing these cases. I will pass the question on to Aaron too for his thoughts.
Scott π
Replying to Erin B. 24/03/2024 - 20:12
Hello Erin.
I hope you are well and enjoying the course. This is a brilliant question.
Dogs with protein-losing enteropathy have an increased risk of thromboembolic disease due to several factors related to the underlying condition. PLE leads to loss of proteins, including anticoagulant proteins like antithrombin, protein C, and protein S, which play crucial roles in regulating the coagulation cascade. This loss can result in a hypercoagulable state, making these dogs more prone to forming blood clots.
Additionally, the loss of proteins, particularly albumin, in PLE can lead to decreased oncotic pressure in the blood vessels. This can cause fluid to leak out of the vessels and into the tissues, leading to oedema and potentially altering blood flow dynamics, further increasing the risk of thrombosis.
Furthermore, the inflammation and tissue damage associated with PLE can activate the coagulation system and promote platelet activation, further contributing to a prothrombotic state.
Overall, the combination of protein loss, alterations in coagulation factors, and inflammation seen in PLE contributes to an increased risk of thromboembolic disease in affected dogs.
Which cases to use clopidogrel in is a whole other question. I would only tend to use it in cases that have more severe protein loss (under 15 g/L). Some people would use it in all cases that have a low albumin. I am not sure we know when exactly to use it, but in PLE cases with more significant reductions in albumin, I definitely would.
I hope that helps!
Scott π
Really interesting topic.
I look forward to hearing people’s thoughts.
Scott π
I have often wondered!
When I worked with you at Wear, we only really used dexmedetomidine.
When I first graduated all we used was medetomidine! I have not seen medetomidine used for quite a while any of the practices I have worked at.
Interested to hear your thoughts.
Scott π
Hey.
I think this is a really interesting topic.
Some cases pose a real challenge. Situations I find tricky are:
1. When a patient is not able to have a NSAID at home due to concurrent medications or medical conditions.
2. Limitations in cats, particularly when paracetamol is not an option.Looking forward to hearing your thoughts.
Scott π
Replying to Felipe M. 16/03/2024 - 13:28
Totally agree.
Involving owners in what we do also adds a layer of complexity.
As with most things, we have to consider every case individually.
Scott π
Replying to Junwei FΓΆhr 21/03/2024 - 10:03
Thank you for being such a brilliant course delegate!
We really appreciate your questions and interaction.
Scott π
Replying to Kerry Doolin 21/03/2024 - 11:37
Kerry!
Like actual talcum powder?! How the heck did they get that in to the pleural space?!
I presume this is not published?
Question is… was it scented?!
Scott π
Replying to Kerry Doolin 21/03/2024 - 11:41
Really interesting Kerry.
I think we have so much more to learn about this drug!
Scott π
Replying to Raquel M. 22/03/2024 - 16:59
That is very exciting!
Congratulation on the new position. If you ever need someone to come out there and do any teaching in person… let me know! π
Scott π
Replying to Josep B. 22/03/2024 - 20:15
Welcome Josep!
Thank you again for working with us. Hope you are having a good weekend.
Scott π
-
AuthorPosts